Pentwater Capital Management
MDLN icon

Pentwater Capital Management’s Medline Inc MDLN Stock Holding History

Pentwater Capital Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
30,000
-20,000
-40% -$806K 0.01% 82
2026
Q1 		$2.23M Buy
+50,000
New +$2.21M 0.01% 76

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Lone Pine Capital
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Pentwater Capital Management's MDLN Position: Q2 2026 in Review

Pentwater Capital Management reduced its Medline Inc (MDLN) stake by 40% in Q2 2026, selling an estimated $806K and leaving 30,000 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #82.

Pentwater Capital Management first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.23M in Q1 2026. 409 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Pentwater Capital Management held 30,000 shares of Medline Inc worth $1.18M as of Q2 2026.
  • Pentwater Capital Management sold 20,000 Medline Inc shares in Q2 2026, an estimated $806K.
  • Medline Inc made up 0.01% of Pentwater Capital Management's portfolio in Q2 2026, its #82 holding.
  • Pentwater Capital Management first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
  • Pentwater Capital Management's Medline Inc position peaked at $2.23M in Q1 2026.
  • 409 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Pentwater Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.